Entre para ver o resumo
Faça login para acessar o resumo da Okai, disponível para usuários cadastrados.
Alterações esclarecem quais entidades podem mensurar investimentos em coligadas e joint ventures pela opção de valor justo no IAS 28.
Faça login para acessar o resumo da Okai, disponível para usuários cadastrados.
In June 2026, the International Accounting Standards Board (IASB) issued Amendments to the Fair Value Option for Investments in Associates and Joint Ventures. The amendments clarified which entities are eligible to measure investments in associates and joint ventures using the fair value option in IAS 28 Investments in Associates and Joint Ventures.
The IASB decided to issue these amendments because stakeholders, particularly those in the insurance industry, informed it about diversity in how the requirements for the fair value option in IAS 28 were being applied. The stakeholders also informed the IASB about the effects of that diversity on the classification of income and expenses in the statement of profit or loss in accordance with IFRS 18 Presentation and Disclosure in Financial Statements.
The IASB decided to develop amendments focusing on the concerns identified, which were:
The IASB concluded that clarifying the meaning of a ‘similar entity’ using the requirements in IFRS 18 that refer to specified main business activities would resolve the identified concerns. Therefore, the amendments clarify that, for the purposes of applying paragraphs 18–19 of IAS 28, similar entities include entities that have a main business activity of investing in particular types of assets (as set out in paragraph 49(a) of IFRS 18).
Nenhum item vinculado a este artefato.